GlassScriptPhysician profile
Judy D Corbett
NPI 1992887111
$1,294.40
in general payments reported to CMS, 2019-2025
21 companies · $294 in 2025
The $294 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $66.96 · 2021: $211 · 2022: $154 · 2023: $108 · 2024: $108 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $384.32 | 2019-2025 | Botox |
| Allergan, INC. | $206.64 | 2019-2022 | |
| Pfizer INC. | $85.84 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $67.79 | 2023-2025 | |
| Therapeuticsmd, INC. | $64.75 | 2019-2020 | |
| Vivus LLC | $64.43 | 2021-2022 | |
| Radius Health, INC. | $60.29 | 2019 | |
| Exact Sciences Corporation | $55.23 | 2023-2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $46.94 | 2019-2025 | Aptima |
| Daiichi Sankyo INC. | $43.94 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $35.04 | 2021 | |
| Myovant Sciences INC. | $33.65 | 2021-2022 | |
| Exeltis, USA INC. | $27.89 | 2023-2024 | Slynd |
| Merck Sharp & Dohme LLC | $21.03 | 2019 | |
| Currax Pharmaceuticals LLC | $15.62 | 2025 | Contrave |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $14.93 | 2021 | |
| Dermira, INC. | $14.43 | 2019 | |
| Avion Pharmaceuticals | $14.09 | 2020 | |
| Novo Nordisk INC | $13.27 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.91 | 2019 | |
| Eisai INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judy Corbett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.